The Manufacturers Life Insurance Company Buys Shares of 70,185 Humana Inc. $HUM

The Manufacturers Life Insurance Company purchased a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent filing with the SEC. The firm purchased 70,185 shares of the insurance provider’s stock, valued at approximately $27,879,000.

Other large investors have also recently made changes to their positions in the company. Manning & Napier Advisors LLC purchased a new stake in shares of Humana during the 2nd quarter worth $1,412,000. Granger Management LLC purchased a new position in Humana in the second quarter valued at about $202,000. Cibc World Market Inc. bought a new position in Humana in the second quarter worth about $6,006,000. OMERS ADMINISTRATION Corp bought a new position in Humana in the second quarter worth about $2,565,000. Finally, Osmosis Investment Management UK Ltd purchased a new stake in shares of Humana during the second quarter valued at about $1,243,000. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a report on Wednesday, July 29th. Needham & Company LLC began coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating for the company. Sanford C. Bernstein restated an “outperform” rating and issued a $425.00 target price on shares of Humana in a research note on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft started coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating on the stock. Finally, Mizuho upped their price target on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average price target of $403.91.

Humana Stock Performance

HUM opened at $392.72 on Friday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $47.16 billion, a P/E ratio of 37.15, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72. The firm’s 50-day moving average price is $385.08 and its 200-day moving average price is $287.78.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same period last year, the business earned $6.27 EPS. As a group, equities analysts anticipate that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.